Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a vaccine therapy in combination with GM-CSF for patients with recurrent or metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Vaccine therapy

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED